Alzheimer’s disease (AD) -Epidemiology Forecast to 2028

"Alzheimers disease (AD) - Epidemiology Forecast, 2028 report provides a comprehensive analysis of the Alzheimers disease (AD) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
United States
EU5 (Germany, France, Italy, Spain, and the United Kingdom)
Japan

Study Period: 2016-2028

Alzheimers disease (AD) Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Alzheimers disease (AD) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders views are also taken into account to provide a deep understanding of the Alzheimers disease (AD) outlook. It also includes the explanation of changing trends of epidemiology outlining the Alzheimers disease (AD) scenario.

Alzheimers disease (AD) Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Alzheimers disease (AD) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
The report covers detailed overview of Alzheimers disease (AD) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
The Alzheimers disease (AD) Report assesses the disease risk and burden and highlights the unmet needs
It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
10 Year Forecast
7MM Coverage
Total Cases in Alzheimers disease (AD)

Key assessments
Patient Segmentation in Alzheimers disease (AD)
Alzheimers disease (AD) Risk & Burden
Factors driving growth in a specific Alzheimers disease (AD) patient population
1. Report Introduction
2. Alzheimers disease (AD) Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Alzheimers disease (AD) in 2016
2.2. Patient Share Distribution of Alzheimers disease (AD) in 2028
3. Disease Background and Overview: Alzheimers disease (AD)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Alzheimers disease (AD) in 7MM
4.3. Total Prevalent/ Incident Patient Population of Alzheimers disease (AD) in 7MM By Countries
5. Epidemiology of Alzheimers disease (AD) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Alzheimers disease (AD)
5.1.3. Sub-Type Specific cases of the Alzheimers disease (AD) *
5.1.4. Sex- Specific Cases of the Alzheimers disease (AD)*
5.1.5. Diagnosed Cases of the Alzheimers disease (AD)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Alzheimers disease (AD)
5.4.3. Sub-Type Specific cases of the Alzheimers disease (AD)*
5.4.4. Sex- Specific Cases of the Alzheimers disease (AD)*
5.4.5. Diagnosed Cases of the Alzheimers disease (AD)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Alzheimers disease (AD)
5.5.3. Sub-Type Specific cases of the Alzheimers disease (AD)*
5.5.4. Sex- Specific Cases of the Alzheimers disease (AD)*
5.5.5. Diagnosed Cases of the Alzheimers disease (AD)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Alzheimers disease (AD)
5.6.3. Sub-Type Specific cases of the Alzheimers disease (AD)*
5.6.4. Sex- Specific Cases of the Alzheimers disease (AD)*
5.6.5. Diagnosed Cases of the Alzheimers disease (AD)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Alzheimers disease (AD)
5.7.3. Sub-Type Specific cases of the Alzheimers disease (AD)*
5.7.4. Sex- Specific Cases of the Alzheimers disease (AD)*
5.7.5. Diagnosed Cases of the Alzheimers disease (AD)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Alzheimers disease (AD)
5.8.3. Sub-Type Specific cases of the Alzheimers disease (AD)*
5.8.4. Sex- Specific Cases of the Alzheimers disease (AD)*
5.8.5. Diagnosed Cases of the Alzheimers disease (AD)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Alzheimers disease (AD)
5.9.3. Sub-Type Specific cases of the Alzheimers disease (AD)*
5.9.4. Sex- Specific Cases of the Alzheimers disease (AD)*
5.9.5. Diagnosed Cases of the Alzheimers disease (AD)
6. Unmet Needs of the Alzheimers disease (AD)
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List Of Tables

Table 1: Total Prevalent/Incident Cases of the Alzheimers disease (AD) in 7MM
Table 2: Total Prevalent/Incident Cases of the Alzheimers disease (AD) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Alzheimers disease (AD) in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Alzheimers disease (AD) in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Alzheimers disease (AD) in United States (2016-2028)*
Table 6: Diagnosed Cases of the Alzheimers disease (AD) in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Alzheimers disease (AD) in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Alzheimers disease (AD) in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Alzheimers disease (AD) in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Alzheimers disease (AD) in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Alzheimers disease (AD) in France (2016-2028)
Table 12: Sub-Type Specific cases of the Alzheimers disease (AD) in France (2016-2028) *
Table 13: Sex- Specific Cases of the Alzheimers disease (AD) in France (2016-2028) *
Table 14: Diagnosed Cases of the Alzheimers disease (AD) in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Alzheimers disease (AD) in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Alzheimers disease (AD) in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Alzheimers disease (AD) in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Alzheimers disease (AD) in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Alzheimers disease (AD) in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Alzheimers disease (AD) in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Alzheimers disease (AD) in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Alzheimers disease (AD) in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Alzheimers disease (AD) in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Alzheimers disease (AD) in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Alzheimers disease (AD) in UK (2016-2028) *
Table 26: Diagnosed Cases of the Alzheimers disease (AD) in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Alzheimers disease (AD) in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Alzheimers disease (AD) in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Alzheimers disease (AD) in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Alzheimers disease (AD) in Japan (2016-2028)


List Of Figures

Figure 1: Total Prevalent/Incident Cases of the Alzheimers disease (AD) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Alzheimers disease (AD) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Alzheimers disease (AD) in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Alzheimers disease (AD) in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Alzheimers disease (AD) in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Alzheimers disease (AD) in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Alzheimers disease (AD) in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Alzheimers disease (AD) in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Alzheimers disease (AD) in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Alzheimers disease (AD) in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Alzheimers disease (AD) in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Alzheimers disease (AD) in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Alzheimers disease (AD) in France (2016-2028) *
Figure 14: Diagnosed Cases of the Alzheimers disease (AD) in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Alzheimers disease (AD) in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Alzheimers disease (AD) in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Alzheimers disease (AD) in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Alzheimers disease (AD) in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Alzheimers disease (AD) in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Alzheimers disease (AD) in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Alzheimers disease (AD) in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Alzheimers disease (AD) in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Alzheimers disease (AD) in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Alzheimers disease (AD) in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Alzheimers disease (AD) in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Alzheimers disease (AD) in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Alzheimers disease (AD) in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Alzheimers disease (AD) in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Alzheimers disease (AD) in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Alzheimers disease (AD) in Japan (2016-2028)


Alzheimer’s Disease: Global Drug Forecast and Market Analysis to 2028

Alzheimers Disease: Global Drug Forecast and Market Analysis to 2028Alzheimers disease (AD) is a progressive neurodegenerative disease that is characterized by memory loss, cognitive impairment, and functional decline. During the

USD 10995 View Report

Alzheimer’s Disease: Epidemiology Forecast to 2028

Alzheimers Disease: Epidemiology Forecast to 2028Alzheimers Disease (AD) is a subtype of dementia and is an irreversible, neurodegenerative brain disease of the elderly. AD is characterized by the death of

USD 3995 View Report

Alzheimer’s Disease: Global Drug Forecast and Market Analysis to 2028

Alzheimers Disease: Global Drug Forecast and Market Analysis to 2028Alzheimers disease (AD) is a progressive neurodegenerative disease that is characterized by memory loss, cognitive impairment, and functional decline. During the

USD 10995 View Report

Alzheimer’s Disease: Epidemiology Forecast to 2028

Alzheimers Disease: Epidemiology Forecast to 2028Alzheimers Disease (AD) is a subtype of dementia and is an irreversible, neurodegenerative brain disease of the elderly. AD is characterized by the death of

USD 3995 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available